SIC 8071 – Medical Laboratories
| Valuation | |
|---|---|
| Market Cap ($M) | 6.29 |
| Enterprise Value ($M) | 4.25 |
| Book Value ($M) | 9.39 |
| Book Value / Share | 0.52 |
| Price / Book | 0.67 |
| NCAV ($M) | 5.43 |
| NCAV / Share | 0.30 |
| Price / NCAV | 1.16 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.10 |
| Return on Assets (ROA) | -0.08 |
| Return on Equity (ROE) | -0.10 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.99 |
| Current Ratio | 4.98 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 7.04 |
| Assets | 11.00 |
| Liabilities | 1.61 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Erayak Power Solution Group Inc. | 18.18 | ||
| 13D | Lai Soo Kow | 7.03 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 95,163 | 565,383 | 16.83 | |
| 8,829,514 | 25,554,514 | 34.55 | |
| 10,868 | 38,170 | 28.47 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CELC – Celcuity Inc. | EXAS – Exact Sciences Corporation |
| MDXH – MDxHealth SA | PMD – Psychemedics Corporation |
| VRDN – Viridian Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io